HLA-C and posterior cortical atrophy: CAR-T cells are genetically engineered T cells that express an artificial T-cell receptor, endowing T-cell populations with the ability to target tumors independently of major histocompatibility-complex (MHC) engagement.322 CAR-T-cell therapy has gained momentum in PCa treatment in clinical trials.